Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$2.05 USD
-0.11 (-5.09%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.06 +0.01 (0.49%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Cardiff Oncology, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CRDF 2.05 -0.11(-5.09%)
Will CRDF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CRDF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRDF
Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know
CRDF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Should You Buy?
Other News for CRDF
Crossed Above 20 Day Moving Average appears for CRDF after 7.46% move
Is CRDF gathering momentum? Bollinger Band Squeeze shows up after climbing 0.5%
Bollinger Band Squeeze appears for CRDF after 1.96% move
The technical outlook for CRDF is unchanged after it falls 0.49% on September 15
NR7 appears for CRDF after 1.44% move